Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-26.82%
operating margin TTM
-31.94%
revenue TTM
1.82 Million
revenue per share TTM
1.13$
valuation ratios | |
|---|---|
| pe ratio | -0.78 |
| peg ratio | -0.04 |
| price to book ratio | 0.60 |
| price to sales ratio | 0.23 |
| enterprise value multiple | -1.92 |
| price fair value | 0.60 |
profitability ratios | |
|---|---|
| gross profit margin | 35.98% |
| operating profit margin | -31.94% |
| pretax profit margin | -26.75% |
| net profit margin | -26.82% |
| return on assets | -27.42% |
| return on equity | -70.27% |
| return on capital employed | -44.79% |
liquidity ratio | |
|---|---|
| current ratio | 3.34 |
| quick ratio | 2.49 |
| cash ratio | 1.41 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 128.25 |
| operating cycle | 191.07 |
| days of payables outstanding | 56.92 |
| cash conversion cycle | 134.15 |
| receivables turnover | 5.81 |
| payables turnover | 6.41 |
| inventory turnover | 2.85 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 1.34 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.09 |
| cash per share | 3.58 |
| operating cash flow per share | 0.11 |
| free cash flow operating cash flow ratio | 0.81 |
| cash flow coverage ratios | 1.34 |
| short term coverage ratios | 1.77 |
| capital expenditure coverage ratio | 5.30 |
Frequently Asked Questions
When was the last time Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) reported earnings?
Sonoma Pharmaceuticals, Inc. (SNOA) published its most recent earnings results on 05-02-2025.
What is Sonoma Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA)'s trailing twelve months ROE is -70.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sonoma Pharmaceuticals, Inc. (SNOA) currently has a ROA of -27.42%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SNOA's net profit margin stand at?
SNOA reported a profit margin of -26.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SNOA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.34 in the most recent quarter. The quick ratio stood at 2.49, with a Debt/Eq ratio of 0.02.